LEADER 02014nam  2200409I  450 
001 9910705662603321
005 20170511142829.0
035   $a(CKB)5470000002451770
035   $a(OCoLC)986799497
035   $a(EXLCZ)995470000002451770
100   $a20170511d2016      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMedicare program, continued action required to address weaknesses in provider and supplier enrollment controls : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /$fstatement of Seto J. Bagdoyan
210  1$a[Washington, D.C.] :$cUnited States Government Accountability Office,$d2016.
215   $a1 online resource (18 pages) $ccolor illustrations
225 1 $aTestimony ;$vGAO-16-703T
300   $a"For release ... May 24, 2016."
320   $aIncludes bibliographical references.
517   $aMedicare program, continued action required to address weaknesses in provider and supplier enrollment controls 
606   $aMedicaid$xCost control$xEvaluation
606   $aMedical care$zUnited States$xCost control$xEvaluation
606   $aWaste in government spending$zUnited States$xPrevention
615  0$aMedicaid$xCost control$xEvaluation.
615  0$aMedical care$xCost control$xEvaluation.
615  0$aWaste in government spending$xPrevention.
702   $aBagdoyan$b Seto J.
712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Energy and Commerce.$bSubcommittee on Oversight and Investigations,
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910705662603321
996   $aMedicare program, continued action required to address weaknesses in provider and supplier enrollment controls : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives$93329767
997   $aUNINA